Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
 
Profit and Loss
Neuland Laboratories Ltd
    Industry   : Pharmaceuticals - Indian - Bulk Drugs  Chairman  : D Saharsh Rao
    Home        : Indian Private  Book Value: 1255.9414887
    BSE Code  : 524558  Market Cap: 19243.17
    NSE Code  : NEULANDLAB  P / E              : 107.92 

Change Company :
(Rs in Cr.)
Profit and Loss
ParticularsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Sales Turnover & Other Income 1573.751571.121200.95953.16953.00
Excise Duty0.000.000.000.000.00
Total Income1560.921626.261210.46968.57954.24
Raw Materials 578.45636.49491.98441.79443.04
Stock Adjustments -12.8355.149.5115.411.24
Other Manufacturing Expenses 108.66103.7382.6984.9273.71
Power & Fuel Cost50.5648.7248.6242.2139.21
Employee Cost 261.40248.53194.84175.76144.02
Selling and Administration Expenses 120.52104.2988.5070.5079.80
Miscellaneous Expenses 22.1110.0422.779.1211.93
Less: Preoperative Expenditure Capitalised0.000.000.000.000.00
Profit before Interest, Depreciation & Tax419.22474.47281.06144.27162.54
Interest & Financial Charges 8.3014.0013.0713.4917.90
Profit before Depreciation & Tax410.92460.47267.99130.78144.64
Depreciation65.5459.7052.7849.0439.68
Profit Before Tax345.38400.77215.2181.74104.96
Tax85.95101.1752.0918.2124.67
Profit After Tax259.43299.60163.1263.5380.29
Adjustment below Net Profit 0.000.000.000.000.00
P & L Balance brought forward747.31460.54303.84244.15166.42
Appropriations 17.9612.836.413.852.57
P & L Bal. carried down988.77747.31460.54303.84244.15
Equity Dividend17.9612.836.413.852.57
Preference Dividend0.000.000.000.000.00
Corporate Dividend Tax0.000.000.000.000.00
Equity Dividend (%)120.00140.00100.0050.0050.00
Earning Per Share (Rs.)201.10232.24126.4449.2562.24
Book Value1175.89988.88765.49647.06605.44
Extraordinary Items 51.90-0.30-0.66-1.369.81
Top
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter / Complaints   |   Smart ODR   |   Scores   |   Attention Investors   | Audit Compliance Report   | RA – Annual Compliance Audit Report 2024-25   | UPI IDs for Payment

SEBI Saa₹thi Mobile App/SEBI Investor Website  

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Designed, Developed & Maintained By
C-MOTS InfoTech(ISO 9001:2015 & ISO/IEC 27001:2022 Certified)
Content powered by Capital Market Charts are powered by TradingView